Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China · Delayed Price · Currency is CNY 14.85
0.00 (0.00%)
Sep 4, 2026, 3:00 PM CST
SHA:603858 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,545 | 1,224 | 818.81 | 694.13 | 2,149 | 1,218 |
Trading Asset Securities | 99.78 | 33.08 | 403.75 | 354.09 | 726.45 | 498.17 |
Cash & Short-Term Investments | 1,644 | 1,258 | 1,223 | 1,048 | 2,875 | 1,716 |
Cash Growth | -26.70% | 2.86% | 16.63% | -63.54% | 67.56% | -7.73% |
Accounts Receivable | 1,182 | 1,612 | 1,258 | 1,887 | 1,905 | 2,171 |
Other Receivables | 96.33 | 93.42 | 114.03 | 152.16 | 164.69 | 200.57 |
Receivables | 1,279 | 1,706 | 1,372 | 2,039 | 2,070 | 2,372 |
Inventory | 4,660 | 4,500 | 4,624 | 4,930 | 3,789 | 3,834 |
Other Current Assets | 428.76 | 430.17 | 317.76 | 263.32 | 257.42 | 430.37 |
Total Current Assets | 8,012 | 7,894 | 7,537 | 8,281 | 8,991 | 8,352 |
Property, Plant & Equipment | 4,636 | 4,796 | 5,664 | 6,000 | 6,301 | 5,919 |
Long-Term Investments | 1,382 | 1,473 | 1,525 | 1,496 | 1,449 | 1,433 |
Goodwill | 400.74 | 400.74 | 620.04 | 1,473 | 2,063 | 5,133 |
Other Intangible Assets | 793.31 | 849.44 | 809.53 | 949.17 | 1,074 | 1,171 |
Long-Term Accounts Receivable | - | - | - | - | 16.75 | 23.32 |
Long-Term Deferred Tax Assets | 354.54 | 347.07 | 389.32 | 368.19 | 221.38 | 220.68 |
Long-Term Deferred Charges | 2,069 | 1,959 | 1,699 | 1,386 | 1,125 | 978.44 |
Other Long-Term Assets | 1,516 | 1,526 | 1,085 | 938.55 | 710.55 | 754.32 |
Total Assets | 19,163 | 19,245 | 19,329 | 20,892 | 21,952 | 23,986 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,908 | 2,537 | 2,846 | 2,497 | 2,398 | 2,495 |
Accrued Expenses | 123.07 | 2,077 | 1,601 | 2,286 | 2,318 | 1,903 |
Short-Term Debt | 400.65 | 358.69 | 486.46 | 240.12 | 638.76 | 1,295 |
Current Portion of Long-Term Debt | 1,122 | 1,001 | 1,123 | 737.93 | 307.04 | 307.42 |
Current Portion of Leases | - | 86.44 | 46.04 | 64.32 | 53.69 | 14.96 |
Current Income Taxes Payable | 127.99 | 78.72 | 81.64 | 83.29 | 95.54 | 118.67 |
Current Unearned Revenue | 398.58 | 352.14 | 215.76 | 238 | 376.52 | 242.4 |
Other Current Liabilities | 2,610 | 679.17 | 702.75 | 709.64 | 773.22 | 786.25 |
Total Current Liabilities | 6,690 | 7,171 | 7,102 | 6,856 | 6,961 | 7,162 |
Long-Term Debt | 2,581 | 2,132 | 1,986 | 2,098 | 2,127 | 1,902 |
Long-Term Leases | 20.74 | 191.76 | 74.62 | 154.58 | 170.37 | 19.14 |
Long-Term Unearned Revenue | 254.81 | 251.37 | 283.59 | 312.29 | 330.55 | 345.63 |
Long-Term Deferred Tax Liabilities | 62.89 | 62.63 | 71.24 | 90.52 | 87.51 | 106.22 |
Other Long-Term Liabilities | 140 | - | 3.02 | 5.07 | - | - |
Total Liabilities | 9,750 | 9,808 | 9,520 | 9,516 | 9,677 | 9,536 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,055 | 1,055 | 1,106 | 1,106 | 1,106 | 1,142 |
Additional Paid-In Capital | 1,732 | 1,732 | 2,493 | 2,493 | 2,494 | 3,392 |
Retained Earnings | 7,583 | 7,267 | 7,318 | 8,008 | 8,751 | 10,806 |
Treasury Stock | -268.42 | - | -712.38 | -1.85 | - | -934 |
Comprehensive Income & Other | -42.61 | -41.93 | 11.23 | 11.84 | 12.13 | 19.3 |
Total Common Equity | 10,059 | 10,012 | 10,216 | 11,617 | 12,363 | 14,425 |
Minority Interest | -645.36 | -575.45 | -408.38 | -240.98 | -87.58 | 25.17 |
Shareholders' Equity | 9,413 | 9,436 | 9,808 | 11,376 | 12,275 | 14,450 |
Total Liabilities & Equity | 19,163 | 19,245 | 19,329 | 20,892 | 21,952 | 23,986 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4,124 | 3,770 | 3,716 | 3,295 | 3,297 | 3,539 |
Net Cash (Debt) | -2,480 | -2,512 | -2,493 | -2,247 | -421.83 | -1,823 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.36 | -2.38 | -2.30 | -2.03 | -0.38 | -1.65 |
Filing Date Shares Outstanding | 1,048 | 1,055 | 1,061 | 1,095 | 1,106 | 1,106 |
Total Common Shares Outstanding | 1,048 | 1,055 | 1,061 | 1,106 | 1,106 | 1,106 |
Working Capital | 1,322 | 722.53 | 435 | 1,425 | 2,030 | 1,190 |
Book Value Per Share | 9.60 | 9.49 | 9.63 | 10.50 | 11.18 | 13.04 |
Tangible Book Value | 8,865 | 8,762 | 8,787 | 9,195 | 9,225 | 8,121 |
Tangible Book Value Per Share | 8.46 | 8.31 | 8.28 | 8.31 | 8.34 | 7.34 |
Buildings | - | 4,404 | 4,891 | 5,036 | 5,195 | 3,211 |
Machinery | - | 2,587 | 2,330 | 2,034 | 1,825 | 1,578 |
Construction In Progress | - | 843.12 | 1,132 | 1,243 | 1,235 | 2,821 |